Global Metronidazole Benzoate Market Size To Worth USD 1.92 Billion By 2033 | CAGR of 6.12%
Category: HealthcareGlobal Metronidazole Benzoate Market Size To Worth USD 1.92 Billion By 2033
According to a research report published by Spherical Insights & Consulting, the Global Metronidazole Benzoate Market Size is Expected to Grow from USD 1.06 Billion in 2023 to USD 1.92 Billion By 2033, at a CAGR of 6.12% during the Forecast Period 2023-2033.
Get more details on this report -
Browse key industry insights spread across 250 pages with 130 Market data tables and figures & charts from the report on the "Global Metronidazole Benzoate Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Capsules, Suspensions, Tablets, and Others), By Applications (Antiprotozoal, Antibacterial, and Others), By Distribution Channel (Clinics, Online Pharmacies, Hospitals, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/metronidazole-benzoate-market
The metronidazole benzoate market is a pharmaceutical drug used to treat bacterial and protozoal infections. It is a common antibiotic used in treating trichomoniasis, parasites, and gastrointestinal diseases. The market is driven by the increasing prevalence of parasitic infections, particularly intestinal ones, which affect 3.5 billion people annually, particularly in developing countries. The demand for metronidazole benzoate medications is also increasing due to the increasing prevalence of gynecologic infections, such as vaginitis, trichomoniasis, bacterial vaginosis, and vulvovaginal candidiasis. The market growth is driven by the widespread availability of efficient medications and growing awareness of infections. The industry is expanding due to rising healthcare costs in developing nations. Novel drug delivery techniques and improvements in pharmaceutical formulations are expected to improve administration simplicity and efficacy. Trends towards self-medication and broad accessibility via Internet pharmacies are also fueling market growth. Profitable prospects are anticipated in the upcoming years due to the accessibility of online drug purchases and pharmaceutical corporations' increasing investment in the R&D sector. However, antibiotic resistance may impede market growth.
The tablets segment held a substantial share in 2023 and is predicted to grow at a significant CAGR during the predicted period.
Based on the product type, the global metronidazole benzoate market is categorized as capsules, suspensions, tablets, and others. Among these, the tablets segment held a substantial share in 2023 and is predicted to grow at a significant CAGR during the predicted period. Segmental expansion is facilitated by effective treatment against protozoal and bacterial infections, novel drug delivery systems, accurate dosing, affordable prices, ease of use, greater absorption, and prevention of postoperative anaerobic bacterial infections.
The antibacterial segment accounted for the highest market share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe.
Based on the applications, the global metronidazole benzoate market is categorized as antiprotozoal, antibacterial, and others. Among these, the antibacterial segment accounted for the highest market share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe.
The tablets and capsules segment accounted for the highest market share of 57.05% in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe. The growth of this segment is attributed to the increasing prevalence of antibacterial infections, particularly mouth, skin, protozoal, gastrointestinal, and vaginal infections.
The hospitals segment accounted for the highest market share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe.
Based on the distribution channel, the global metronidazole benzoate market is categorized as clinics, online pharmacies, hospitals, and others. Among these, the hospitals segment accounted for the highest market share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe. The segment's growth is attributed to increased inpatient and outpatient services, large bed services, advanced medical devices, personalized medications, specialized healthcare, and skilled doctors and nurses enhancing patient health outcomes.
North America is expected to hold the greatest share of the global metronidazole benzoate market over the forecast period.
Get more details on this report -
North America is expected to hold the greatest share of the global metronidazole benzoate market over the forecast period. The growth of the pharmaceutical market is driven by high healthcare costs, widespread knowledge, and advanced medical facilities. The availability of various treatment options and large pharmaceutical companies contribute to this expansion, particularly in the United States with a reliable healthcare system and high bacterial and protozoal disease rates.
Asia Pacific is predicted to grow at the fastest CAGR throughout the estimated period. The growth of the healthcare market is fueled by a large patient base, rising healthcare spending, and increased accessibility to medical treatments, particularly in countries like China, India, and Japan, which are experiencing a rise in bacterial and protozoal diseases.
Major key players in the global metronidazole benzoate market are Novartis AG, Torrent Pharmaceuticals Ltd., Aurobindo Pharma Ltd., Sanofi, Glenmark Pharmaceuticals Ltd., Mylan N.V., Lupin Limited, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Johnson and Johnson, Cipla Limited, Zydus Cadila, Merck & Co., Inc., and others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In November 2023, Kesin Parma Corporation, a pharmaceutical company focused on innovative Specialty brands and Unit dose formulations received the U.S. Food and Drug Administration (USFDA) for the LIKMEZ (metronidazole) oral suspension, 500mg/5 mL.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global metronidazole benzoate market based on the below-mentioned segments:
Global Metronidazole Benzoate Market, By Product Type
- Capsules
- Suspensions
- Tablets
- Others
Global Metronidazole Benzoate Market, By Applications
- Antiprotozoal
- Antibacterial
- Others
Global Metronidazole Benzoate Market, By Distribution Channel
- Clinics
- Online Pharmacies
- Hospitals
- Others
Global Metronidazole Benzoate Market, By Regional
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?